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AbstrAct
Objective To project the proportion of population 65+ 
years with severe long-term activity limitations from 2017 
to 2047.
Design Large population study.
setting Population living in private households of the 
European Union (EU) and neighbouring countries.
Participants Participants from the EU Statistics on 
Income and Living Conditions aged 55 years and older and 
living in one of 26 EU and neighbouring countries, who 
answered the health section of the questionnaire.
Outcome measures Prevalence of severe long-term 
activity limitations of particular subpopulations (ie, 55+, 
65+, 75+ and 85+ years) by sex and country.
results We find a huge variation in the prevalence of 
self-reported severe long-term limitations across Europe 
for both sexes. However, in 2017, about 20% of the 
female population aged 65 years and above and about 
16% of their male counterparts are expected to report 
severe long-term activity limitations after accounting for 
differences in reporting. Accounting for cultural differences 
in reporting, we expect that European countries will have 
about 21% (decile 1: 19.5%; decile 9: 22.9%) of female 
and about 16.8% (decile 1: 15.4%; decile 9: 18.1%) of 
male 65+ years population with severe long-term activity 
limitations by 2047.
conclusions Overall, despite the expected increase of 
life expectancy in European countries, our results suggest 
almost constant shares of older adults with severe long-
term activity limitations within the next 30 years.
IntrODuctIOn
Worldwide populations are growing older. In 
upper middle-income and high-income coun-
tries, life expectancy is increasing and fertility 
rates are declining, leading to an increase of 
older  populations.  However,  there  is  a  lack  
of  evidence  whether  these  demographic  
changes  are  accompanied  by  an  increase  of  
frail  or  morbid people.  The health status  of  
older population is of raising public interest 
and  a  broadly  discussed  issue  since  many  
countries fear a rise in economic costs caused 
by ageing.
During  the  last  decades,  a  large  body  of  
literature  focused  on  health  trends,  which  
were  often  analysed  with  indicators  using  
health-specific  life  expectancies.1–3  Research  
on  trends  in  healthy  life  years  (HLYs)  and  
disability-free  life  expectancy  showed  an  
inconsistent pattern. For instance, in the early 
2000s,  healthy  life  expectancy  showed  only  
little change for European men and women 
in contrast to their life expectancy,4  whereas 
it  increased  significantly  between  the  early  
1980s  and  2000s  in  Austria.5  Other  studies  
showed  that  in  the  USA,  higher  educated  
population  experienced  some  compression  
of  morbidity,  whereas  their  lower  educated  
counterparts showed an expansion.6
There  are  inequalities  in  health  expec-
tancies  at  older  ages  across  the  European  
Union (EU) and even within countries,  and 
there  are  discrepancies  between  men  and  
women.1  Even  though  women  benefit  from  
their  mortality  advantage  over  men  when  it  
comes to HLYs, the situation is sometimes the 
opposite.  Women  in  general  report  higher  
prevalence  of  disabilities  and  frailty.7  Some  
research already explored this health-survival 
paradox.8 9
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Research
strengths and limitations of this study
 ► We  used  data  on  26  European  countries  collected  
annually between 2008 and 2014.
 ► Applying  the  Sullivan  method,  we  computed  life  
expectancy  without  severe  long-term  activity  
limitations  (healthy  life  years  (HLYs))  by  sex  and  
5-year age groups.
 ► We model  the  ratio  of  HLYs  and  life  expectancy  to  
predict  prevalence  of  severe  activity  limitations  
among older adults.
 ► Cultural  differences  in  self-reports  are  
acknowledged,  so  we  used  a  random  intercept  
approach to consider those properly.
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Less  research  was  focused  on  the  impact  of  possible  
future  trends  in  healthy  and  disability-free  life  expec-
tancy  on  the  socioeconomic  development  of  a  country.  
For instance, are European health systems prepared for 
higher  shares  of  older  adults?  Should we expect  higher  
proportions of unhealthy older population?
The objective of this study is to provide an outlook on 
the future health status of older population measured by 
living with severe long-term limitations in daily activities. 
Based on the EU Statistics on Income and Living Condi-
tions (SILC) survey, we project the share of the 65+ years 
population living with severe long-term activity limitations 
for 26 European countries by 2047.
DAtA AnD methOD
Data
We used the EU-SILC data, which are conducted annually 
within EU member states and a few additional European 
states.10  This  cross-sectional  and  longitudinal  microdata  
provide  information  on  income,  poverty,  social  exclu-
sion and living conditions. Eurostat has coordinated the 
EU-SILC data since 2003, whereas national statistical insti-
tutes have collected the information, first in 6 countries 
and  by  2014  in  31  countries.11  Although  the  sampling  
procedure varies across countries, the samples are consid-
ered nationally representative of individuals aged at least 
16 years living in private households.10 11 In our study, we 
focus on the global  activity  limitation indicator (GALI),  
which was designed for monitoring HLYs (ie, life expec-
tancy  without  long-term  activity  limitations)  within  the  
EU.12  This  measure  of  general  activity  limitations  was  
shown  to  be  significantly  associated  with  other  health  
measures such as functional limitations, activities of daily 
living  and  instrumental  activity  of  daily  living.13  Since  
2008,  GALI  addresses  the  long-term  activity  limitations  
with the question ‘For at least the past 6 months, to what 
extent have you been limited because of a health problem 
in  activities  people  usually  do?’.  There  are  some  minor  
variations in the wording for the kind of activities across 
some countries ranging from usual, normal to daily activ-
ities  (see  ref  14).  Therefore,  we  recoded  the  response  
categories ‘limited, but not severely’ and ‘not limited at 
all’ as having no severe difficulties and ‘severely limited’ as 
with severe limitations. Moreover, there might be variations 
in  self-reports  across  cultures  due  to  the  uncertainty  in  
defining ‘limited, but not severely’, so our recoding addi-
tionally addresses this potential bias.
We investigated the EU-SILC data provided by Eurostat 
restricting on the population aged at least 55 years from 
2008 to 2014 on an aggregated level by country, sex and 
5-year  age  groups.  We  also  used  sex-specific  life  tables  
provided  by  Eurostat  for  each  country  and  each  of  our  
corresponding  survey  years.15  In  addition,  we  used  
sex-specific  life  tables  and  age-specific  and  sex-specific  
population  projections  from  2015  to  2050  provided  by  
the  United  Nations  following  the  medium  projection  
variant assumptions.16
methods
Prevalences  of  bad general  health status  are  proxied by  
self-reported  presence  of  long-term  activity  limitations  
(ie, the GALI). Sample weights are considered to account 
for  non-response,  so  that  the  data  are  nationally  repre-
sentative for the non-institutionalised population. Using 
the  sex-specific  and  age  group-specific  prevalence  rates  
and Eurostat life tables, we applied the Sullivan method 
to  compute  health-specific  life  expectancy,  that  is,  
remaining  life  expectancy  without  severe  long-term  
activity limitations (also called healthy life years) for each 
country by 5-year age groups between 2008 to 2014.17 We 
determined  sex-specific  and  age-specific  HLY  for  each  
survey  year  and  computed  r ,  the  ratio  of  HLY  and  life  
expectancy.4 18
Since  our  estimation  of  HLY  is  based  on  the  self-re-
ported activity limitation status, country-specific cultural 
norms may play a crucial role in explaining big difference 
in the prevalence of severe long-term activity limitations. 
The generosity of social security systems may also play an 
important role in differences between countries.  In this  
study, we tried to minimise this bias due to reporting style 
with regressing the ratio of HLY to life expectancy by sex 
for 26 upper middle-income and high-income countries 
across  Europe  using  random  intercept  model.19  The  
significant  group  effect  was  identified  with  likelihood  
ratio  tests  for  men  and  women.  The  between  country  
variance  explained  more  than  80%  of  the  variance  in  
r,  the  ratio  of  HLY  to  life  expectancy,  which  supported  
our motivation to extinguish the potential cultural differ-
ences in self-reports.
Furthermore, we tested the importance of time, hence 
if  there is  a  change in the proportion of  remaining life  
years  spent  without  severe  long-term  activity  limitations  
(HLY/LE) over the years. While women showed no signif-
icant change across time, we identified a small significant 
increase of r  among men. Nevertheless, this increase was 
on average <0.025 units per year, which can be read as a 
prevalence increase of <0.5% points per year. Therefore, 
we decided to ignore this time effect for simplicity reasons 
and run the following model separately by sex
 
logit(ric) = β0 +
8∑
i=2
βiDic + u0c + εic
 (1)
with Dic  a dummy variable for the 5-year age groups,  
indicating the first level aggregated by age group and year 
and c indicates the country group (second level).
Next,  we  used  the  sex-specific  United  Nations  life  
tables  for  the  years  2015–2050  to  project  HLY  by  age  
for  those  years  using  estimated  r̄i,  which  represents  the  
age  group-specific  ratio  averaged  across  all  countries.  
In  order  to  perform  comparative  analysis,  we  used  a  
sex-specific and age group-specific overall r̄i  for all coun-
tries, rather than applying the country-specific estimated 
r̄ic because of the huge variation in country effects, which 
might  be  defined  by  cultural  and  norm  differences  in  
countries under consideration.20
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Figure 1 Self-reported severe activity limitations among at least 65 years old women across 26 European countries in 2014.
Figure 2 Self-reported severe activity limitations among at least 65 years old men across 26 European countries in 2014.
Having r̄i and the sex-specific projected life expectancy 
by age, we were able to calculate sex-specific HLY by age 
and to estimate the prevalence rate of people with severe 
long-term  activity  limitations,  subsequently.  Moreover,  
we  projected  the  prevalence  rate  of  people  with  severe  
long-term activity limitations and the proportion of older 
adults with severe long-term activity limitations from 2017 
to 2047 using age-specific and sex-specific United Nations 
population projections.
Since  we  applied  the  overall  r̄i  for  all  countries,  the  
differences  emerging  in  projected  trends  of  prevalence  
of  severe  long-term  activity  limitations  depend  only  on  
population age composition and projected life expectan-
cies. Moreover, while life expectancy is increasing and the 
ratio  of  HLY and life  expectancy  remains  constant  over  
time, HLY has to increase and it can decrease only with 
higher age. Hence, overall sex-specific and age group-spe-
cific good general health increases as well, which implies 
a decline in severe long-term activity limitations.
In  addition,  we  performed  some  sensitivity  analysis  
considering uncertainty in the estimates and provided a 
prediction interval around projected prevalences.
results
Comparing observed prevalence rates of severe long-term 
activity  limitations of  older adults  (ie,  65+ years  popula-
tion)  across  Europe,  we  identified  huge  disparities  in  
the health of  older  adults  across  the investigated upper  
middle-income and high-income countries for both men 
and  women  (figures  1  and  2).  For  instance,  in  2012  in  
Sweden, only 9.99% of the female 65+ years population 
reported  severe  long-term  limitations,  whereas  about  
34.15%  of  their  counterparts  in  Slovakia  reported  bad  
health  (table  1).  The  range  is  a  bit  narrower  for  the  
male  65+  years  population,  the  prevalence  rates  were  
between 6.44% and 27.6% in Malta and Slovakia, subse-
quently (table 1). In all countries, more women than men 
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Table 1 Prevalence rates of women and men aged at least 55, 65, 75 and 85 years with severe long-term activity limitations 
for 26 European countries in 2012
Country
Women Men
55+ 65+ 75+ 85+ 55+ 65+ 75+ 85+
Austria 19.1 23.3 32.6 46.4 17.3 19.9 28.5 40.6
Bulgaria 8.6 11.5 16.3 19.8 7.0 9.9 15.4 26.5
Czech Republic 12.6 15.9 25.4 33.6 10.1 11.6 19.4 27.9
Estonia 22.0 27.8 36.7 54.8 19.5 23.2 31.2 36.5
Finland 12.7 15.3 21.8 24.9 11.4 14.6 21.3 29.3
France 19.3 24.6 32.5 44.7 14.8 18.6 27.3 35.6
Germany 22.8 27.0 38.4 53.3 19.3 21.1 25.2 39.8
Greece 24.9 30.8 39.8 47.0 18.3 23.4 30.9 38.9
Hungary 17.3 22.9 32.4 42.5 14.8 18.6 25.0 38.9
Iceland 21.7 22.1 23.1 22.9 12.8 15.1 18.6 33.3
Ireland 9.3 11.6 15.0 27.6 11.2 14.4 18.5 27.4
Italy 20.8 27.2 37.6 49.3 15.0 19.8 27.5 34.4
Latvia 15.6 20.6 28.0 33.9 13.4 18.9 21.8 35.9
Lithuania 19.0 25.0 33.8 61.4 15.1 18.8 25.1 40.3
Luxembourg 13.0 17.0 21.0 20.0 11.1 13.2 18.7 27.2
Malta 8.5 12.2 23.0 36.9 5.2 6.4 12.4 15.1
Netherlands 9.6 11.6 16.6 17.6 9.4 10.4 15.5 16.4
Poland 15.8 21.4 30.5 43.9 14.8 19.1 26.0 39.9
Portugal 19.8 25.5 33.3 44.6 14.5 18.9 25.6 33.0
Romania 21.7 28.3 39.7 55.6 15.1 20.5 31.4 42.4
Slovakia 24.9 34.1 47.8 59.1 20.5 27.6 45.0 78.4
Slovenia 23.5 30.2 41.0 47.0 18.4 21.3 19.6 38.5
Spain 13.3 17.8 26.0 37.4 9.9 12.3 18.0 27.6
Sweden 10.2 10.0 12.7 15.3 7.2 8.0 14.0 22.5
Switzerland 10.2 11.3 14.7 18.9 8.1 8.7 10.7 15.3
UK 21.8 26.4 35.1 44.8 17.1 19.8 27.4 37.4
reported  severe  long-term  activity  limitations,  although  
women tend to have higher life expectancy than men.
However,  we  observed  a  very  pronounced  difference  
in the prevalence of severe long-term activity limitations 
also  among  the  countries  where  remaining  life  expec-
tancy at age 65 years often differs very little. Considering 
these  variations  between  countries,  our  random  inter-
cept regression showed a decline in the ratio of HLY to 
life expectancy by age, as expected. Moreover,  the clear 
decline  by  age  was  of  almost  the  same  magnitude  for  
both sexes (see online supplementary tables S1 and S2). 
Hence, men and women experienced the same speed of 
health deterioration.
We  showed  that  the  so-called  burden  of  unhealthy  
population is very similar across European countries (see 
table  2),  if  we  exclude  cultural  differences  in  reporting  
and  consider  only  differences  in  age  structure  and  life  
expectancy.
Controlling for cultural bias in self-reports, we noticed 
some changes over time in the ranking of countries with 
the  highest  and  lowest  level  of  older  adults  with  severe  
activity  limitations.  For  instance,  Lithuania  followed  by  
Latvia had the highest shares of unhealthy 65 years and 
older adults in 2017. In 2047, Germany and the Nether-
lands  can  be  expected  to  have  the  highest  proportion  
of men above age 65 years with severe long-term activity 
limitations.
Furthermore,  our  results  demonstrate  almost  no  
increase  of  the  proportion  of  people  with  severe  long-
term  activity  limitations  for  most  European  countries  
participating  in  EU-SILC.  These  results  are  valid  both  
for  men and women (see  table  2).  Within 30 years,  the  
magnitude  of  change  in  the  proportion  of  people  65+  
years is less than 2.5% points among the female popula-
tion and even smaller among men (2% points).
In  the  online  supplementary  figures  S1  and  S2,  we  
show the  prediction intervals  of  the  proportion of  men 
and  women  at  ages  65+  years  based  on  uncertainty  in  
parameter  estimations  related  to  the  age  effects.  Very  
little uncertainty in age effects is translated into relatively 
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Table 2 Prevalence rates of at least 65 years old women and men with severe long-term activity limitations for 26 European 
countries in 2017, 2027, 2037 and 2047; in parentheses change since 2017.
Country
Women Men
2017 2027 2037 2047 2017 2027 2037 2047
Austria 20.68 20.21 (−0.47) 19.96 (−0.72) 21.40 (0.72) 16.17 15.93 (−0.24) 15.96 (−0.21) 17.25 (1.08)
Bulgaria 21.27 21.70 (0.43) 21.95 (0.68) 21.66 (0.39) 17.11 17.29 (0.18) 17.32 (0.21) 17.12 (0.01)
Czech 
Republic
20.02 20.89 (0.87) 21.49 (1.47) 20.63 (0.61) 15.83 16.46 (0.63) 16.7 (0.87) 16.16 (0.33)
Estonia 21.49 21.21 (−0.28) 21.73 (0.24) 21.86 (0.37) 16.85 16.48 (−0.37) 16.74 (−0.11) 16.80 (−0.05)
Finland 19.80 20.37 (0.57) 21.86 (2.06) 21.87 (2.07) 15.48 16.21 (0.73) 17.30 (1.82) 17.24 (1.76)
France 20.26 19.81 (−0.45) 20.71 (0.45) 21.52 (1.26) 15.94 16.08 (0.14) 16.76 (0.82) 17.20 (1.26)
Germany 21.22 20.61 (−0.61) 20.52 (−0.7) 22.28 (1.06) 16.56 16.20 (−0.36) 16.31 (−0.25) 17.79 (1.23)
Greece 21.01 20.72 (−0.29) 20.51 (−0.5) 21.06 (0.05) 17.11 16.74 (−0.37) 16.39 (−0.72) 16.58 (−0.53)
Hungary 21.05 21.34 (0.29) 21.87 (0.82) 21.01 (−0.04) 16.64 16.91 (0.27) 17.09 (0.45) 16.51 (−0.13)
Iceland 19.71 18.95 (−0.76) 20.06 (0.35) 21.01 (1.3) 15.43 15.15 (−0.28) 16.30 (0.87) 16.75 (1.32)
Ireland 19.25 19.37 (0.12) 19.78 (0.53) 19.86 (0.61) 15.43 15.57 (0.14) 15.82 (0.39) 15.97 (0.54)
Italy 20.62 20.36 (−0.26) 20.19 (−0.43) 21.51 (0.89) 16.27 16.20 (−0.07) 16.11 (−0.16) 17.07 (0.8)
Latvia 21.98 21.52 (−0.46) 21.74 (−0.24) 22.22 (0.24) 17.40 16.93 (−0.47) 17.05 (−0.35) 17.22 (−0.18)
Lithuania 22.21 21.24 (−0.97) 21.41 (−0.8) 22.61 (0.4) 18.27 16.92 (−1.35) 17.05 (−1.22) 17.57 (−0.7)
Luxembourg 20.51 19.26 (−1.25) 19.29 (−1.22) 20.24 (−0.27) 15.84 15.22 (−0.62) 15.45 (−0.39) 16.43 (0.59)
Malta 19.68 20.74 (1.06) 21.43 (1.75) 21.09 (1.41) 15.55 16.28 (0.73) 16.93 (1.38) 16.58 (1.03)
Netherlands 19.76 19.90 (0.14) 20.68 (0.92) 22.09 (2.33) 15.60 15.86 (0.26) 16.50 (0.9) 17.62 (2.02)
Poland 20.14 19.91 (−0.23) 21.77 (1.63) 21.03 (0.89) 15.98 15.85 (−0.13) 17.05 (1.07) 16.43 (0.45)
Portugal 20.73 20.45 (−0.28) 20.55 (−0.18) 21.12 (0.39) 16.53 16.33 (−0.2) 16.48 (−0.05) 16.88 (0.35)
Romania 21.24 21.15 (−0.09) 21.27 (0.03) 21.36 (0.12) 16.98 16.88 (−0.1) 16.88 (−0.1) 16.95 (−0.03)
Slovakia 20.29 20.21 (−0.08) 21.29 (1) 20.80 (0.51) 16.11 16.10 (−0.01) 16.86 (0.75) 16.38 (0.27)
Slovenia 20.76 20.14 (−0.62) 20.85 (0.09) 21.45 (0.69) 15.95 15.77 (−0.18) 16.56 (0.61) 16.91 (0.96)
Spain 20.69 19.86 (−0.83) 19.73 (−0.96) 20.64 (−0.05) 16.40 15.88 (−0.52) 15.81 (−0.59) 16.53 (0.13)
Sweden 20.05 20.71 (0.66) 20.95 (0.9) 21.18 (1.13) 15.68 16.49 (0.81) 16.67 (0.99) 16.94 (1.26)
Switzerland 20.12 19.74 (−0.38) 19.82 (−0.3) 21.04 (0.92) 15.71 15.69 (−0.02) 15.91 (0.2) 16.91 (1.2)
UK 20.37 20.25 (−0.12) 20.36 (−0.01) 21.25 (0.88) 16.07 16.13 (0.06) 16.20 (0.13) 16.87 (0.8)
narrow  prediction  intervals.  The  trends  in  proportion  
of  people  with  severe  long-term  activity  limitations  are  
almost constant for most countries (eg,  Estonia,  Greece 
and Hungary). However, Germany and some other coun-
tries  showed  a  slight  increase  and  only  a  few  countries  
such as Poland showed a slight decline in the proportion 
of  people  with  severe  long-term activity  limitations  (see  
online supplementary figures S1 and S2).
DIscussIOn
In  this  analysis  of  EU-SILC data,  we  investigated  self-re-
ports  in  severe  activity  limitations  of  older  adults  in  26  
upper middle-income and high-income countries across 
Europe.  Our  results  showed  that  HLY  differ  consider-
ably, which might be explained by self-reports. Countries 
with relatively similar levels of mortality, life expectancies 
and  health  systems  are  not  expected  to  differ  much  in  
HLY  apart  from  cultural  differences  in  self-reports.  For  
instance, Germany and the Netherlands are very similar 
in their remaining life expectancy at age 65 years (21 years 
for females and about 18 years for men), but they differ 
in  terms  of  remaining  life  years  without  severe  activity  
limitations; there is a gap of 3 years for women and about 
2  years  for  men  (women:  15  years  Germany,  18.4  years  
Netherlands; men: 13.8 years Germany, 18.4 years Neth-
erlands).  Moreover,  these  potential  cultural  differences  
in self-reports are supported by our investigations in the 
ratio  of  HLY  and  life  expectancy.  Country  differences  
explained  80%  of  the  difference  in  the  ratio.  Another  
issue that may lead to the differences in self-reporting is 
the  generosity  of  the  welfare  system.  In  more  generous  
systems, higher reports of severe long-term activity limita-
tions might go together with the easier access to disability 
benefits. There might be also ‘true’ differences in self-re-
ported  health  attributed  to  different  life  styles  in  Euro-
pean countries or differences in genetics.  However, one 
6 Scherbov S, Weber D. BMJ Open 2017;7:e017654. doi:10.1136/bmjopen-2017-017654
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would expect that morbidity and disability  are also rela-
tively close, if the levels of mortality are very close.
We also showed that the ratio of remaining life expec-
tancy  without  severe  long-term  activity  limitations  to  
the  total  remaining  life  expectancy  does  not  change  
with  time  for  women  and  only  little  for  men  and  that  
the  so-called  burden  of  unhealthy  population  is  very  
similar across European countries once potential cultural 
differences  in  self-reports  are  excluded.  Furthermore,  
the  general  concern  that  ageing  is  accompanied  by  an  
increase of disability may occur in the absolute level only, 
but more importantly, the proportion of adults aged 65+ 
years with severe long-term activity limitations will remain 
almost  constant  in  the  upcoming  years,  although  total  
life expectancy is expected to increase. A recent study on 
disabilities  (ie,  difficulties  with  activities  of  daily  living)  
suggests  similar  trends of  no increase in the prevalence 
for England and Wales by 2025, but an increase of older 
people  with  care  needs  in  absolute  numbers.21  Interest-
ingly,  research  on  trends  between  1991  and  2011  using  
different English data showed that while more life years 
are spent healthy, less severe disabilities are increasing.22 
This increase in less severe disabilities might be in conse-
quence  of  variations  in  self-reports  as  also  identified  in  
our study or an increase in obesity.
However,  there  may  be  important  policy  implications  
derived  from  our  results  on  trends  in  severe  long-term  
activity  limitations.  Even  though  the  trends  in  propor-
tion of people with limitations will remain constant, the 
absolute number of people with severe long-term activity 
limitations  will  definitely  increase  since  the  number  
of  people  at  older  ages  is  expected  to  increase  in  most  
European  countries.  It  might  require  several  measures  
to  accommodate  the  needs  of  an  increasing  number  
of  people  with  activity  limitations  such  as  expanding  
infrastructure  for  disabled  people  in  the  public  as  well  
as  private  area,  training  of  medical  specialists  and  care  
professionals.
Some  limitations  of  this  study  should  be  noted.  First  
of  all,  EU-SILC  survey  does  not  cover  the  institution-
alised population. Even though we have included sample 
weights  to  control  for  non-response,  there  was  nothing  
we  could  do  to  include  the  institutionalised  population  
within  our  projections.  Another  limitation  is  the  appli-
cation of  Sullivan method to compute HLY rather  than 
using  panel  data,  and  calculating  multistate  life  tables,  
but  this  is  more  a  data  limitation.  Nevertheless,  our  
study on future trends in the prevalence of severe long-
term  activity  limitations  confirms  a  recent  comment  by  
Kenneth Rockwood. He stated that we should not expect 
to spend our whole life in good health,23 rather European 
countries  might  expect  more  older  adults  with  severe  
long-term  activity  limitations  but,  in  relative  terms,  the  
number stays constant.
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